Kings Point Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $10.7M | Buy |
96,762
+5,814
| +6% | +$614K | 0.93% | 43 |
|
|
2021
Q4 | $9.41M | Buy |
90,948
+6,773
| +8% | +$784K | 0.77% | 46 |
|
|
2021
Q3 | $10.6M | Buy |
84,175
+3,728
| +5% | +$483K | 0.94% | 40 |
|
|
2021
Q2 | $9.99M | Buy |
80,447
+1,668
| +2% | +$209K | 0.91% | 43 |
|
|
2021
Q1 | $9.31M | Buy |
78,779
+6,103
| +8% | +$715K | 0.92% | 44 |
|
|
2020
Q4 | $8.51M | Buy |
72,676
+4,573
| +7% | +$503K | 0.91% | 45 |
|
|
2020
Q3 | $7.08M | Buy |
68,103
+4,475
| +7% | +$449K | 0.88% | 45 |
|
|
2020
Q2 | $5.83M | Buy |
63,628
+2,685
| +4% | +$257K | 0.85% | 45 |
|
|
2020
Q1 | $5.5M | Buy |
60,943
+7,663
| +14% | +$815K | 0.97% | 42 |
|
|
2019
Q4 | $6.04M | Buy |
53,280
+2,440
| +5% | +$268K | 0.89% | 44 |
|
|
2019
Q3 | $5.52M | Buy |
50,840
+2,349
| +5% | +$245K | 0.93% | 43 |
|
|
2019
Q2 | $4.72M | Buy |
48,491
+4,185
| +9% | +$382K | 0.86% | 47 |
|
|
2019
Q1 | $4.04M | Buy |
44,306
+584
| +1% | +$52.3K | 0.8% | 49 |
|
|
2018
Q4 | $3.98M | Buy |
43,722
+22,753
| +109% | +$2.13M | 0.89% | 48 |
|
|
2018
Q3 | $2.06M | Buy |
+20,969
| New | +$1.94M | 0.38% | 73 |
|
|
2017
Q3 | – | Sell |
-1,225
| Closed | -$109K | – | 365 |
|
|
2017
Q2 | $109K | Sell |
1,225
-575
| -32% | -$48.5K | 0.03% | 172 |
|
|
2017
Q1 | $145K | Hold |
1,800
| – | – | 0.03% | 152 |
|
|
2016
Q4 | $128K | Hold |
1,800
| – | – | 0.03% | 149 |
|
|
2016
Q3 | $156K | Hold |
1,800
| – | – | 0.04% | 128 |
|
|
2016
Q2 | $156K | Hold |
1,800
| – | – | 0.04% | 129 |
|
|
2016
Q1 | $135K | Hold |
1,800
| – | – | 0.03% | 130 |
|
|
2015
Q4 | $138K | Hold |
1,800
| – | – | 0.03% | 137 |
|
|
2015
Q3 | $120K | Hold |
1,800
| – | – | 0.03% | 158 |
|
|
2015
Q2 | $133K | Hold |
1,800
| – | – | 0.03% | 148 |
|
|
2015
Q1 | $140K | Buy |
+1,800
| New | +$136K | 0.04% | 148 |
|
|
2014
Q4 | – | Sell |
-1,800
| Closed | -$112K | – | 353 |
|
|
2014
Q3 | $112K | Sell |
1,800
-20,000
| -92% | -$1.27M | 0.03% | 133 |
|
|
2014
Q2 | $1.39M | Buy |
21,800
+20,000
| +1,111% | +$1.21M | 0.42% | 49 |
|
|
2014
Q1 | $111K | Hold |
1,800
| – | – | 0.04% | 123 |
|
|
2013
Q4 | $103K | Hold |
1,800
| – | – | 0.04% | 124 |
|
|
2013
Q3 | $96K | Hold |
1,800
| – | – | 0.04% | 130 |
|
|
2013
Q2 | $93K | Buy |
+1,800
| New | +$89K | 0.04% | 142 |
|
Other funds holding MDT
WA
Kings Point Capital Management's MDT Position: Q1 2022 in Review
Kings Point Capital Management increased its Medtronic (MDT) stake by 6.4% in Q1 2022, buying an estimated $614K and bringing the position to 96,762 shares worth $10.7M. The position accounts for 0.93% of the portfolio, ranked #43.
Kings Point Capital Management first reported a position in MDT in Q2 2013 and has held it in 31 quarters since. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.
- Kings Point Capital Management held 96,762 shares of Medtronic worth $10.7M as of Q1 2022.
- Kings Point Capital Management bought 5,814 Medtronic shares in Q1 2022, an estimated $614K.
- Medtronic made up 0.93% of Kings Point Capital Management's portfolio in Q1 2022, its #43 holding.
- Kings Point Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 31 quarters since.
- 2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.
Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.